MedPath

Univo IRB Expands Services with Canadian Research Ethics Board Review

a year ago2 min read

Key Insights

  • Univo IRB has launched Canadian Research Ethics Board (REB) review services to support clinical trials across North America, ensuring high ethical and regulatory standards.

  • The new service aims to streamline the REB approval process for researchers and sponsors, facilitating more efficient clinical trials in compliance with Canadian guidelines.

  • Univo IRB's Canadian REB includes experts in ethics, law, and science, guided by the Tri-Council Policy Statement for ethical research involving humans.

Univo IRB, a leader in ethical review and oversight for clinical research, has announced the launch of its Canadian Research Ethics Board (REB) review services. This initiative is designed to support clinical trials conducted throughout North America, ensuring that all reviews meet the highest standards of ethical integrity and regulatory compliance.
The introduction of Canadian ethical review services represents a significant expansion of Univo IRB’s capabilities. This new service will provide researchers and sponsors with a streamlined process for obtaining Canadian REB approval, thereby facilitating smoother and more efficient clinical trials.

Expert Oversight and Comprehensive Support

According to Cyrus Gill, Executive Chair of Univo IRB, the Canadian REB includes experts in ethics, law, and scientific disciplines, as well as community ambassadors. "Under the guidance of the Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans, this diverse group brings together experts in ethics, law, and scientific disciplines, alongside respected community ambassadors," said Gill. "By assembling this distinguished board for Canada and adhering to both Canadian and international regulatory requirements, we reaffirm our dedication to advancing research outside the U.S. responsibly and ethically, while unifying clinical research with our passion for patient protection, education, and advocacy."
Univo IRB’s Canadian REB review services offer a comprehensive suite of support, including expedited review timelines, detailed feedback, and ongoing oversight throughout the trial lifecycle. This proactive approach is designed to minimize delays and ensure that trials can proceed efficiently without compromising ethical standards.

About Univo IRB

Univo IRB, formerly Principal IRB, specializes in the ethical review of Phase I-IV pharmaceutical, device, biologic, behavioral, and psycho-social research. The organization offers agile study approaches, expert solutions powered by industry-leading study technology, and a service-first approach. Univo IRB holds accreditation through the Association for the Accreditation of Human Research Protection Programs (AAHRPP).
Subscribe Icon

Stay Updated with Our Daily Newsletter

Get the latest pharmaceutical insights, research highlights, and industry updates delivered to your inbox every day.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.